Mammary Neoplasms in Female Dogs: Identification of Cytopathological Criteria for MalignancyKamiguchi IE*, Moreira IM, Da Silva Trindade F, Zahn FS, Hataka A and Sousa Rocha N
Department of Pathology, Universidade Estadual Paulista Julio de Mesquita Filho, Botucatu, São Paulo 18618-970, Brazil
- *Corresponding Author:
- Emy Kamiguchi I
Department of Pathology, Universidade Estadual Paulista Julio de Mesquita Filho
Botucatu, São Paulo 18618-970, Brazil
E-mail: [email protected]
Received Date: October 26, 2015; Accepted Date: December 28, 2015; Published Date: January 02, 2016
Citation: Kamiguchi IE, Moreira IM, Da Silva TF, Zahn FS, Hataka A, et al. (2016) Mammary Neoplasms in Female Dogs: Identification of Cytopathological Criteria for Malignancy. J Cytol Histol 7:392. doi:10.4172/2157-7099.1000392
Copyright: © 2016 Kamiguchi IE, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Mammary neoplasms have high incidence in both women and female dogs, with such a cytological resemblance between species that studies in canines might work as a baseline for research regarding the incidence in women, due to the relatively high incidence of this cancer, similar biologic behavior, large body size, comparable responses to cytotoxic agents, and shorter overall lifespan. Given the relevance of this neoplasm and the practicality of the cytological examination, studies listing the classification criteria for these tumors gains importance, aiding in diagnosis precision.
Aim and Objective: Therefore, this research paper aims at identifying and standardizing criteria that may be relevant for the diagnosis of malignancy in cytopathological preparations from mammary tumors in female canines. Once the cytopathological malignancy criteria are identified, we aim at verifying whether there is variation in the tumor’s degree of aggressiveness considering the criteria established for mammary cancer in women.